Vimarsana
Biggest News Aggregation in the World

Page 6 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Pricing Program Today - Breaking & Trending Today

经济篇之N(第5节): The Inflation Reduction Act (IRA) of 2022 and Drug - 博客 - Vimarsana News

经济篇之N(第5节): The Inflation Reduction Act (IRA) of 2022 and Drug - 博客

IntheU.S.,severalkeylegislationshaveaprofoundimpactongovernmentpricingofdrugs,especiallywithinpublichealthprogramslikeMedicare...

Providers, drugmakers at odds over new 340B dispute resolution process - Vimarsana News

Providers, drugmakers at odds over new 340B dispute resolution process

Healthcare

340B Remedy Rule and Medicare Advantage Rates: Navigating Shifting Payments | McDermott Will & Emery - Vimarsana News

340B Remedy Rule and Medicare Advantage Rates: Navigating Shifting Payments | McDermott Will & Emery

On April 1, 2024, the Centers for Medicare & Medicaid Services (CMS) released the Announcement of Calendar Year (CY) 2025 Medicare Advantage (MA) Capitation Rates and Part C and Part D...

As Big Pharma tries to block low-cost drug program, states push back | Guest Commentary - Vimarsana News

As Big Pharma tries to block low-cost drug program, states push back | Guest Commentary

Guest Commentary: States are pushing back against attempts by drug companies to roll back a discount program “safety net” health providers use to care for vulnerable, low-income Americans.

Commentary: Some states push back on blocking low-cost drug program - Vimarsana News

Commentary: Some states push back on blocking low-cost drug program

In recent years, drug manufacturers have declined to offer 340B discounts on their covered outpatient drugs, creating disruption for the patients who rely on them